On May one, 2009, there was a recall of 14 Hydroxycut diet-aid products springing from a number of reports that people using the products were developing major liver problems and other health worries. Less than seven days later, on May 4, the 1st Hydroxycut class action lawsuit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Class Action Lawsuit alleges company neglectfulness in informing the public about potential perils of the products. Naturally, it’s too soon to understand the suit is going to turn out, but if the company had information which it did not reveal to consumers, it should definitely be held accountable.

A class action court action is filed by a group of folks, all of whom have similar claims against a certain company. Filing a class action is just as effective, and far less expensive, than filing an individual suit. As a rule, filing a class action legal action will not cost you anything unless there is a settlement. At that point, the attorney who handled the suit will take his fees from the compensation that was awarded and then distribute the remaining funds to the plaintiffs in the case. Since this is the case, you will be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the explanations that class action suits became so popular.

The initial class action lawsuit against Iovate was filed in Canada where the company is located and represents all Canadian citizens who sustained health issues due to Hydroxycut products. The FDA recall happened in the US Where twenty-three cases of liver disorders and other health problems had been reported. Health Canada did not receive any reports of liver damage due to the diet products, but they did receive 17 reports concerning folks who sustained respiration, neurological, cardio, and stomach problems as a result of Canadians using the products.

The Hydroxycut Settlement Suit alleges that the company sold the general public of the health hazards that they could exposing consumers to. The complaint states that the company failed to publish the data on the product labels saying that users could run the chance of liver and kidney damage as well as stomach, cardio, respiration, and neurological problems. The suit goes on to allege that this was a blatant omission on the part of the company which purposely misled buyers concerning the security of the products.